A recent study using comparative proteomics analyzed 363 proteins expressed in glioma cells and confirmed that the inhibition of NK-cell cytotoxicity is mediated by the HLA-E expressed in tumor cells [31]. The gene discussed is HLA-E; the disease is glioma.